These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9576476)

  • 21. Endotoxin measures in patients' sample: how valid are the results?
    Stadlbauer V; Davies NA; Wright G; Jalan R
    J Hepatol; 2007 Nov; 47(5):726-7; author reply 727-3. PubMed ID: 17850915
    [No Abstract]   [Full Text] [Related]  

  • 22. Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis.
    Ruan P; Gong ZJ; Zhang QR
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):58-61. PubMed ID: 14969839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progress of endotoxin and chronic liver disease].
    Wang L; Ren CS
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):251-3. PubMed ID: 12716536
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of anti-endotoxin therapy on vaso-active substances in decompensated liver cirrhosis].
    Zhuang L; Ma Z; Liu T
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):94-5. PubMed ID: 10861114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis].
    Lata J; Juránková J; Príbramská V; Fric P; Senkyrík M; Díte P; Kroupa R
    Vnitr Lek; 2006 Mar; 52(3):215-9. PubMed ID: 16722152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endotoxin and antiendotoxin antibodies in patients with acute pancreatitis.
    Buttenschoen K; Berger D; Hiki N; Buttenschoen DC; Vasilescu C; Chikh-Torab F; Seidelmann M; Beger HG
    Eur J Surg; 2000 Jun; 166(6):459-66. PubMed ID: 10890542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.
    Albillos A; de la Hera A; González M; Moya JL; Calleja JL; Monserrat J; Ruiz-del-Arbol L; Alvarez-Mon M
    Hepatology; 2003 Jan; 37(1):208-17. PubMed ID: 12500206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence study of metastases in cirrhotic livers.
    Pereira-Lima JE; Lichtenfels E; Barbosa FS; Zettler CG; Kulczynski JM
    Hepatogastroenterology; 2003; 50(53):1490-5. PubMed ID: 14571771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cirrhotic cardiomyopathy].
    Kim MY; Baik SK
    Korean J Hepatol; 2007 Mar; 13(1):20-6. PubMed ID: 17380071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of substance P in the pathogenesis of spider angiomas in patients with nonalcoholic liver cirrhosis.
    Li CP; Lee FY; Hwang SJ; Chang FY; Lin HC; Lu RH; Hou MC; Chu CJ; Chan CC; Luo JC; Lee SD
    Am J Gastroenterol; 1999 Feb; 94(2):502-7. PubMed ID: 10022654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of osteoporosis in liver cirrhosis.
    Giouleme OI; Vyzantiadis TA; Nikolaidis NL; Vasiliadis TG; Papageorgiou AA; Eugenidis NP; Harsoulis FI
    Hepatogastroenterology; 2006; 53(72):938-43. PubMed ID: 17153457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection.
    Attallah AM; Toson el-SA; El-Waseef AM; Abo-Seif MA; Omran MM; Shiha GE
    Clin Chim Acta; 2006 Jul; 369(1):66-72. PubMed ID: 16545356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endotoxin-neutralizing capacity of serum from cardiac surgical patients.
    Bennett-Guerrero E; Barclay GR; Weng PL; Bodian CA; Feierman DE; Vela-Cantos F; Mythen MG
    J Cardiothorac Vasc Anesth; 2001 Aug; 15(4):451-4. PubMed ID: 11505348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.
    Alam I; Bass NM; Bacchetti P; Gee L; Rockey DC
    Am J Gastroenterol; 2000 Jan; 95(1):199-203. PubMed ID: 10638583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of cisapride on intestinal bacterial and endotoxin translocation in cirrhotic rats].
    Zhang SC; Wang W; Ren WY; Zhou K; He BM; Zhu WN
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):539-41. PubMed ID: 14552714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous intracranial hemorrhage in cirrhotic patients.
    Huang HH; Lin HH; Shih YL; Chen PJ; Chang WK; Chu HC; Chao YC; Hsieh TY
    Clin Neurol Neurosurg; 2008 Mar; 110(3):253-8. PubMed ID: 18194837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of cirrhosis and portal hypertension on mortality following colorectal surgery: a nationwide, population-based study.
    Nguyen GC; Correia AJ; Thuluvath PJ
    Dis Colon Rectum; 2009 Aug; 52(8):1367-74. PubMed ID: 19617746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis.
    Kajihara M; Kato S; Okazaki Y; Kawakami Y; Ishii H; Ikeda Y; Kuwana M
    Hepatology; 2003 Jun; 37(6):1267-76. PubMed ID: 12774004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.